254 related articles for article (PubMed ID: 22391996)
1. No evidence for mevalonate shunting in moderately affected children with Smith-Lemli-Opitz syndrome.
Roullet JB; Merkens LS; Pappu AS; Jacobs MD; Winter R; Connor WE; Steiner RD
J Inherit Metab Dis; 2012 Sep; 35(5):859-69. PubMed ID: 22391996
[TBL] [Abstract][Full Text] [Related]
2. Feedback inhibition of the cholesterol biosynthetic pathway in patients with Smith-Lemli-Opitz syndrome as demonstrated by urinary mevalonate excretion.
Pappu AS; Steiner RD; Connor SL; Flavell DP; Lin DS; Hatcher L; Illingworth DR; Connor WE
J Lipid Res; 2002 Oct; 43(10):1661-9. PubMed ID: 12364550
[TBL] [Abstract][Full Text] [Related]
3. Increased nonsterol isoprenoids, dolichol and ubiquinone, in the Smith-Lemli-Opitz syndrome: effects of dietary cholesterol.
Pappu AS; Connor WE; Merkens LS; Jordan JM; Penfield JA; Illingworth DR; Steiner RD
J Lipid Res; 2006 Dec; 47(12):2789-98. PubMed ID: 16983147
[TBL] [Abstract][Full Text] [Related]
4. Regulation of cholesterol biosynthetic pathway in patients with the Smith-Lemli-Opitz syndrome.
Honda M; Tint GS; Honda A; Salen G; Shefer S; Batta AK; Matsuzaki Y; Tanaka N
J Inherit Metab Dis; 2000 Jul; 23(5):464-74. PubMed ID: 10947201
[TBL] [Abstract][Full Text] [Related]
5. 7-Dehydrocholesterol-dependent proteolysis of HMG-CoA reductase suppresses sterol biosynthesis in a mouse model of Smith-Lemli-Opitz/RSH syndrome.
Fitzky BU; Moebius FF; Asaoka H; Waage-Baudet H; Xu L; Xu G; Maeda N; Kluckman K; Hiller S; Yu H; Batta AK; Shefer S; Chen T; Salen G; Sulik K; Simoni RD; Ness GC; Glossmann H; Patel SB; Tint GS
J Clin Invest; 2001 Sep; 108(6):905-15. PubMed ID: 11560960
[TBL] [Abstract][Full Text] [Related]
6. Hepatic isoprenoid metabolism in a rat model of Smith-Lemli-Opitz Syndrome.
Keller RK; Mitchell DA; Goulah CC; Fliesler SJ
Lipids; 2013 Mar; 48(3):219-29. PubMed ID: 23361583
[TBL] [Abstract][Full Text] [Related]
7. Effects of dietary cholesterol and simvastatin on cholesterol synthesis in Smith-Lemli-Opitz syndrome.
Chan YM; Merkens LS; Connor WE; Roullet JB; Penfield JA; Jordan JM; Steiner RD; Jones PJ
Pediatr Res; 2009 Jun; 65(6):681-5. PubMed ID: 19430384
[TBL] [Abstract][Full Text] [Related]
8. Sterol balance in the Smith-Lemli-Opitz syndrome. Reduction in whole body cholesterol synthesis and normal bile acid production.
Steiner RD; Linck LM; Flavell DP; Lin DS; Connor WE
J Lipid Res; 2000 Sep; 41(9):1437-47. PubMed ID: 10974051
[TBL] [Abstract][Full Text] [Related]
9. Cholesterol supplementation with egg yolk increases plasma cholesterol and decreases plasma 7-dehydrocholesterol in Smith-Lemli-Opitz syndrome.
Linck LM; Lin DS; Flavell D; Connor WE; Steiner RD
Am J Med Genet; 2000 Aug; 93(5):360-5. PubMed ID: 10951458
[TBL] [Abstract][Full Text] [Related]
10. Residual cholesterol synthesis and simvastatin induction of cholesterol synthesis in Smith-Lemli-Opitz syndrome fibroblasts.
Wassif CA; Krakowiak PA; Wright BS; Gewandter JS; Sterner AL; Javitt N; Yergey AL; Porter FD
Mol Genet Metab; 2005 Jun; 85(2):96-107. PubMed ID: 15896653
[TBL] [Abstract][Full Text] [Related]
11. 7-Dehydrocholesterol down-regulates cholesterol biosynthesis in cultured Smith-Lemli-Opitz syndrome skin fibroblasts.
Honda M; Tint GS; Honda A; Nguyen LB; Chen TS; Shefer S
J Lipid Res; 1998 Mar; 39(3):647-57. PubMed ID: 9548596
[TBL] [Abstract][Full Text] [Related]
12. Lowered DHCR7 activity measured by ergosterol conversion in multiple cell types in Smith-Lemli-Opitz syndrome.
Ginat S; Battaile KP; Battaile BC; Maslen C; Gibson KM; Steiner RD
Mol Genet Metab; 2004; 83(1-2):175-83. PubMed ID: 15464432
[TBL] [Abstract][Full Text] [Related]
13. Quantitative proteomics analysis of inborn errors of cholesterol synthesis: identification of altered metabolic pathways in DHCR7 and SC5D deficiency.
Jiang XS; Backlund PS; Wassif CA; Yergey AL; Porter FD
Mol Cell Proteomics; 2010 Jul; 9(7):1461-75. PubMed ID: 20305089
[TBL] [Abstract][Full Text] [Related]
14. Sterols and oxysterols in plasma from Smith-Lemli-Opitz syndrome patients.
Griffiths WJ; Abdel-Khalik J; Crick PJ; Ogundare M; Shackleton CH; Tuschl K; Kwok MK; Bigger BW; Morris AA; Honda A; Xu L; Porter NA; Björkhem I; Clayton PT; Wang Y
J Steroid Biochem Mol Biol; 2017 May; 169():77-87. PubMed ID: 26976653
[TBL] [Abstract][Full Text] [Related]
15. Cholesterol treatment forever? The first Scandinavian trial of cholesterol supplementation in the cholesterol-synthesis defect Smith-Lemli-Opitz syndrome.
Starck L; Lövgren-Sandblom A; Björkhem I
J Intern Med; 2002 Oct; 252(4):314-21. PubMed ID: 12366604
[TBL] [Abstract][Full Text] [Related]
16. Bile acid synthesis in the Smith-Lemli-Opitz syndrome: effects of dehydrocholesterols on cholesterol 7alpha-hydroxylase and 27-hydroxylase activities in rat liver.
Honda A; Salen G; Shefer S; Batta AK; Honda M; Xu G; Tint GS; Matsuzaki Y; Shoda J; Tanaka N
J Lipid Res; 1999 Aug; 40(8):1520-8. PubMed ID: 10428990
[TBL] [Abstract][Full Text] [Related]
17. Biochemical and Clinical Effects of Vitamin E Supplementation in Hungarian Smith-Lemli-Opitz Syndrome Patients.
Koczok K; Horváth L; Korade Z; Mezei ZA; Szabó GP; Porter NA; Kovács E; Mirnics K; Balogh I
Biomolecules; 2021 Aug; 11(8):. PubMed ID: 34439893
[TBL] [Abstract][Full Text] [Related]
18. Vitamin D levels in Smith-Lemli-Opitz syndrome.
Movassaghi M; Bianconi S; Feinn R; Wassif CA; Porter FD
Am J Med Genet A; 2017 Oct; 173(10):2577-2583. PubMed ID: 28796426
[TBL] [Abstract][Full Text] [Related]
19. A placebo-controlled trial of simvastatin therapy in Smith-Lemli-Opitz syndrome.
Wassif CA; Kratz L; Sparks SE; Wheeler C; Bianconi S; Gropman A; Calis KA; Kelley RI; Tierney E; Porter FD
Genet Med; 2017 Mar; 19(3):297-305. PubMed ID: 27513191
[TBL] [Abstract][Full Text] [Related]
20. Mutations in the human sterol delta7-reductase gene at 11q12-13 cause Smith-Lemli-Opitz syndrome.
Wassif CA; Maslen C; Kachilele-Linjewile S; Lin D; Linck LM; Connor WE; Steiner RD; Porter FD
Am J Hum Genet; 1998 Jul; 63(1):55-62. PubMed ID: 9634533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]